Press Releases
RNA Editing for Neurodegenerative Diseases Market to Reach USD 1,026.82 Million by 2036
Advances in central nervous system delivery, expanding genetic target discovery and investment in RNA-based therapeutic platforms are shaping the market’s growth outlook, according to
FMI
October 13, 2026